by Samsara@8529 | May 24, 2023 | Home, News
News Article Samsara Therapeutics Parkinson’s drug receives funding boost from The Michael J. Fox Foundation Monday 22nd May 2023. Samsara Therapeutics, a biotech committed to harnessing autophagy to prevent disease and increase health span, announced today... by Samsara@8529 | Apr 27, 2023 | Home, News
News Article Samsara Therapeutics unveils promising autophagy drug candidate, offering new hope for people with Parkinson’s and motor neurone disease Wednesday 26th April 2023. Today’s announcement from Chief Scientific Officer, Peter Hamley, puts Samsara... by Amy Dickinson | Nov 8, 2022 | Blog, Home
Insights / News Article Meet the Neuro Team – Modelling Neurodegeneration in a Dish Nov 7, 2022 We caught up with Senior Scientists Gabriela Vilema Enríquez and Matthew Williamson on their work within the neuroscience team at Samsara. Small but Mighty ... by Samsara@8529 | Oct 13, 2022 | Home, News
News Article CMT Research Foundation and Samsara Therapeutics Partner on a Novel Therapeutic Approach for CMT1A with the Potential to Reach Clinical Trials ATLANTA, GA and OXFORD, UK (October 13, 2022) The CMT Research Foundation (CMTRF), a non-profit focused... by Samsara@8529 | Sep 21, 2022 | Blog, Home
Insights / News Article Meet Nicole – From Books to Bench Sep 21, 2022 Hear from Nicole Mak, a Biology student at Bath University, on her year in industry with Samsara. Why Samsara? The research role at Samsara aligned perfectly with my passions and skillset. I have... by Samsara@8529 | Jan 5, 2022 | Home, News
News Article Samsara Therapeutics Establishes Scientific Advisory Board Michael Schlossmacher, Susan Perlman, Ed Tate and Christian Behl to help advance development of neurodegeneration and rare genetic disease therapeutics Oxford, UK and Boston, US, 06 January...